Ticker Symbol: HZNP
Horizon Therapeutics Plc
$107.60 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001492426
Company Profile
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The Company pipeline is purposeful: it applyie scientific expertise and courages to bring clinically meaningful therapies to patients. The Company believes science and compassion must work together to transform lives.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.horizontherapeutics.com
CEO: Timothy P Walbert
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $116.23
Change:
$0.30
(
0.26%)
Days Range: $116.17 - $116.27
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 2.13%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 228994568
Valuation
Market Cap: 2.7T
PE Ratio: 62.16
EPS (TTM): 1.87
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A